Brain Tumours

Summary

• GBM exhibit multiple genetic abnormalities • Inter- and intra-patient heterogeneity • Targeting single pathways ineffective to date • Tumour specificity essential • Immunological/vaccine therapies have potential • DNA damage response also a potential target